Page 3 - Amnio Breathe Hensler BioLabs 2020
P. 3
Amnio Breathe™ Treatment Outcomes
Dec 21, 2018 – January 24, 2019
• 15 ½ year old male
• Swimmer
• Asthma sufferer for 12 years
• Used maintenance inhaler (mometasone furoate/formoterol fumarate
dihydrate) 2x day in AM, rescue inhaler (albuterol sulfate) as needed, one
tablet cetirizine daily
• Chronic post-nasal drip; sometimes so severe he cannot swim for fear of
the feeling of ‘drowning’.
• Secondary airways consistent at +/- 70% for previous 12 months (possibly
longer…compiling data)
• Received 2cc of Amnio Breathe™ through our T-App nebulizer
• 4 days after treatment, all post-nasal drip was cleared; stopped taking
Cetirizine
• 4 days after treatment, stopped using chemical inhalers
• Re-tested 34 days later. 22% improvement in secondary airways
13825 N. Northsight Blvd.
Suite 101
Scottsdale, AZ 85260
480.207.1884
info@BioLabSciences.net
